Effect of blood letting on serum aminotransferase levels of patients with chronic hepatitis C and iron overload

Recenti Progressi in Medicina

Volumn 89, Issue 5, 1998, Pages 241-244

  Girelli, Carlo M ^a,c   Mirata, Carla ^a   Casiraghi, Antonietta ^b  

^a Ospedale Civile   (Italy)

^b Ospedale   (Italy)

^c NONE   (Italy)

Author keywords

Aminotransferase; Blood letting; Ferritin; Hepatitis C; Interferon alpha; Iron; Siderosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ASPARTATE AMINOTRANSFERASE; FERRITIN; IRON; TRANSFERRIN; VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; IRON OVERLOAD; ITALY; MALE; PHLEBOTOMY; PROSPECTIVE STUDY;

ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IRON OVERLOAD; MALE; MIDDLE AGED; PHLEBOTOMY; PROSPECTIVE STUDIES;

EID: 0031810139     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Di Biscieglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992, 102: 2108-13.
2. Piperno A, D'Alba R, Fargion S, et al. Liver iron concentration in chronic viral hepatitis: a study of 98 patients. Eur J Gastroenterol Hepatol 1995, 7: 1203-8.
3. Van Thiel DH, Friedlander L, Fagiuoli S, Wright HI, Irish W, Gavaler JS. Response to interferon α therapy is influenced by the iron content of the liver. J Hepatol 1994, 20: 410-15.
4. Olynyk JK, Reddy KR, Di Biscieglie AM, et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995, 108: 1104-9.
5. Girelli CM, Mirata C, Lesinigo E, Casiraghi A. Iron overload and response to α-interferon in chronic hepatitis C. Am J Gastroenterol 1995, 90: 170-1.
6. Turlin B, Juguet F, Moirand R, et al. Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. Hepatology 1995, 22: 446-50.
7. Piperno A, Roffi L, Pozzi M, et al. Can iron depletion therapy ameliorate hepatocellular injury in anti HCV positive chronic hepatitis? Gastroenterology 1992, 102: A868.
8. Hayashi H, Takikawa T, Nishimura N, Yano M, Isomura T, Sakamoto N. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol 1994, 89: 986-8.
9. Bacon BR, Rebholz AE, Fried M, Di Biscieglie AM. Beneficial effect of iron reduction therapy in patients with chronic hepatitis C who failed to respond to interferon-α. Hepatology 1993,18: 150A.
10. Van Thiel DH, Friedlander L, Malloy P et al. Retreatment of hepatitis C interferon non-responders with larger doses of interferon with and without phlebotomy. Gastroenterology 1994,106: A1002.
11. Barry M, Sherlock S. Measurement of liver-iron concentration in needle biopsy specimens. Lancet 1971, 1: 100-109.
12. Scheuer P, Williams R, Muir A. Hepatic pathology in relatives of patients with hemochromatosis. J Pathol Bacteriol 1962; 84: 53-64.
13. Yudkin PL, Stratton IM. How to deal with regression to the mean in intervention studies. Lancet 1996; 347: 241-3.
14. Hayashi H, Takikawa T, Nishimura N, Yano M. Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C. J Hepatol 1995, 22: 268-71.
15. Bullen JJ, Spalding PB, Ward G, Gutteridge JMC. Hemochromatosis, iron and septicemia caused by Vibrio vulnificus. Arch Intern Med 1991, 151: 1606-9.
16. Bird TF, Horwitz MA. Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J Clin Invest 1989; 83: 1457-65.
17. Moncada S. The L-arginine nitric oxide pathway. Acta Physiol Scand 1992; 145: 201-27.
18. Kuhn LC. Molecular regulation of iron proteins. Baillieres Clin Haematol 1994; 7: 763-85.
19. Farinati F, Cardin R, De Maria N, et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti HCV positive patients. J Hepatol 1995, 22: 449-56.
20. Gutteridge JMC, Rowley DA, Griffiths E, Halliwell B. Low-molecular-weight iron complexes and oxigen radical reactions in idiopathic haemochromatosis. Clin Sci 1985, 68: 463-7.
21. Halliwell B, Gutteridge JMC. Oxygen, free radicals and iron in relation to biology and medicine. Some problems and concepts. Arch Biochem Biophys 1986; 246: 501-14.
22. Salonen JT, Korpela H, Nyyssonen K, et al. Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: a randomized cross-over trial in male smokers. J Intern Med 1995, 237: 161-8.
23. Kugelmas M, Yen Lieberman B, Carey WD. Deironization in chronic hepatitis C patients previously non-responsive to interferon improves transaminases but not viral activity. Gastroenterology 1995; 108: A1104.